User talk:INDIAHEARTTRANSPLANT

HEART TRANSPLANTATION INDIA
Very Few heart transplants were done in India prior to 2012 on yearly basis. Regular Heart transplants with help of Cadaver Allocation from Online waitlisting was started in 2012 by Dr KR Balakrishnan, DR R Ravi Kumar and KG Suresh Rao in Chennai. This also spurred regular Cadaver donation in Tamil NAdu and then other states in India. Dr Ravikumar, Dr Balakrishnan and SUresh Rao are also credited for Validating the First optimal immunosuppression regime for indian patients. These were for drugs like Basiliximab, Tacrolimus and Mycophenolate. Also Dr R Ravikumar and team were the First to use the Kidney sparing drug Everolimus in Indian Heart transplant recipients. Dr R Ravikumar and Dr KR Balakrishnan also Showed value of Limited Endomyocardial biopsies ( EM Biopsies) in Indian patients along with Impact of Pulmonary Hypertension in Indian Heart transplant patients. Dr Ravikumar was also the First to show the value of CYP3A5 genetic metaboliser status to tailor immunosuppression for calcinuerin anatgonists like tacrolimus in Indian heart transplant patients. Dr R Ravikumar and dr KR Balakrishnan with Others like Dr AGK Gokhale, Dr Kewal Krishan , Manoj Durairaj were also instrumental in Setting up the Prestigious Indian Society for Heart and lung Transplantation ( INSHLT). Dr R Ravikumar, Dr KR Balakrishnan are few Indian faculty for the International Society for Heart and lung Transplant, USA.

REFERENCES : 1.Balakrishnan KR, Ravikumar R, Suresh Rao KG et al. Medium term results following Heart Transplantation in 257 cases : a single center experience. Ind H Journal. Nov 2020. doi.org/10.1016/j.ihj.2020.09.010.

2.Ravi Kumar R. Vigil Rahulan et al Tailored Immunosuppression using CYP3A5 Metaboliser status in Heart and Lung Transplant cases - An Indian Study. J heart lung Transplant ,April 2020 ;39(4) : 303. Abstracts from Annual meeting ISHLT 2020.

3.. Ravi Kumar R. Prabhat Dutta, Sandeep Attawar. Heart Transplant in India : Gleneagles Global Experience. Journal of the Practice of Cardiovascular sciences, August 2019 :Vol5  ; 91-93

4.Anoop Mohandas, R Ravi Kumar et al Early Low dose Everolimus is safe and effective in Heart Transplant Patients with reduced Post operative Renal Function. ACC Middle East / Emirates Cardiac Society Annual Meeting Abu Dhabi. October 2019

5.K Balakrishnan, Ratnagiri R et al Limiting the Number of Endomyocardial Biopsies does not impact one year survival after Heart Transplant. J heart Lung Transplant. J Heart lung Transplant. Supplement .April 2016 Volume 35; Issue 4, Supplement : S210